Importance Prenatal antiseizure medication (ASM) exposure has been associated with
adverse early neurodevelopment, but associations with a wider range of psychiatric end …

Importance Women with epilepsy frequently need antiseizure medication (ASM) to prevent
seizures in pregnancy. Risk of neurodevelopmental disorders after prenatal exposure to …

Background Maternal use of valproate during pregnancy has been associated with an
increased risk of neurodevelopmental disorders in children. Although most studies of other …

Importance Use of valproate and certain other antiseizure medications (ASMs) in pregnancy
is associated with abnormal fetal brain development with potential long-term implications for …

Background and Objectives To undertake a systematic review of the available literature to
examine the relationship between prenatal antiseizure medication (ASM) exposure and …

Importance The neurodevelopmental risks of fetal exposure are uncertain for many
antiseizure medications (ASMs). Objective To compare children at 2 years of age who were …

Importance There is concern about neurodevelopmental outcomes associated with prenatal
exposure to valproate and other antiepileptic drugs (AEDs) among children of mothers with …

Background The neurodevelopmental effects of fetal exposure to most antiseizure
medications are unclear. We aimed to investigate the effects of fetal exposure to commonly …

Objectives In utero exposure to antiepileptic drugs has previously been associated with
adverse outcome among offspring, but evidence on longer term milestone development …

Objective To assess the association between exposure to monotherapy with 10 different
antiepileptic drugs (AEDs) during the first 2 months of pregnancy and the risk of 23 major …